Experienced Class Action Lawyers and Complex Litigation Attorneys
In the Nexium pay-for-delay multidistrict litigation accusing drug companies of violating antitrust laws by agreeing to delay entry of a generic version of AstraZenca’s heartburn drug Nexium, federal Judge William Young may be reconsidering some of[...]
The debate over "reverse payment" patent litigation settlements continues following the Supreme Court's decision in FTC v. Actavis that such agreements should be individually evaluated to determine whether they violate the anti-trust laws. Reverse payment settlements[...]